A call for principle-based acceptance of synthetic patients: establishing the AI-driven foundation for regulatory submissions
{{output}}
The pharmaceutical industry stands at the precipice of an AI-driven data revolution, with synthetic patients emerging as a transformative tool to accelerate drug discovery and development while enhancing patient privacy. However, a critical regulatory gap pers... ...
